Researchers compared QOL and other outcomes between patients with endometrial cancer who took short-course adjuvant VCB and ...

The following is a summary of “Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated ...

The high health care burden faced by individuals with hemophilia underscores the urgent need for innovative treatments and ...

You know that moment when life takes an unexpected turn? That’s exactly what happened when I started researching stem cell ...

When facing multiple myeloma, learning about the disease, understanding treatment options, and knowing how to deal with the ...

In a comprehensive analysis of more than 100 clinical trials involving nearly 15,000 adults, researcher have found that there ...

By automating certain tasks, such as clinical documentation, AI allows healthcare providers to focus more on the patient ...

Research presented at SABCS 2024 highlighted efforts to expand treatment options for early breast cancer as well as ...

Researchers have identified three distinct subtypes of osteosarcoma, a rare bone cancer, using advanced mathematical modeling ...

Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...